Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,188 | 14,776 | 35,119 | 34,067 | 0 |
| Marketable Securities | 16,515 | 16,615 | N/A | N/A | 0 |
| TOTAL | $60,184 | $31,965 | $35,579 | $34,276 | $0 |
| Non-Current Assets | |||||
| PPE Net | 895 | 756 | 654 | 434 | N/A |
| Other Non-Current Assets | 88 | 93 | 93 | 275 | 0 |
| TOTAL | $983 | $849 | $747 | $709 | $N/A |
| Total Assets | $61,167 | $32,814 | $36,326 | $34,985 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 948 | 875 | 1,069 | 605 | 0 |
| Accrued Expenses | 1,146 | 1,211 | 845 | 1,205 | 0 |
| TOTAL | $2,094 | $2,086 | $1,914 | $1,810 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11 | 7 | 0 | 0 | 0 |
| TOTAL | $11 | $7 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,105 | $2,093 | $1,914 | $1,810 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6 | 5 | 5 | 5 | N/A |
| Common Shares | 18 | 13 | 14 | 3 | 0 |
| Retained earnings | -21,291 | -16,134 | -11,942 | -8,824 | 0 |
| Other shareholders' equity | 1 | -6 | 0 | 41,192 | 0 |
| TOTAL | $59,062 | $30,721 | $34,412 | $33,175 | $0 |
| Total Liabilities And Equity | $61,167 | $32,814 | $36,326 | $34,985 | $0 |